2014
In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients With Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention
Bagai A, Wang Y, Wang TY, Curtis JP, Gurm HS, Shah B, Cheema AN, Peterson ED, Saucedo JF, Granger CB, Roe MT, Bhatt DL, McNamara RL, Alexander KP. In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients With Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention. Circulation Cardiovascular Interventions 2014, 7: 585-593. PMID: 25097196, DOI: 10.1161/circinterventions.114.001555.Peer-Reviewed Original ResearchMeSH KeywordsAcute DiseaseAge FactorsAgedClopidogrelDrug SubstitutionFemaleHumansMaleMiddle AgedMyocardial InfarctionPercutaneous Coronary InterventionPiperazinesPostoperative ComplicationsPractice Guidelines as TopicPrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsRecurrenceRegistriesRisk FactorsThiophenesThrombosisTiclopidineUnited StatesConceptsPercutaneous coronary interventionMyocardial infarctionCoronary interventionHospital coronary artery bypassIntervention Outcomes Network RegistryStudy periodAcute Coronary TreatmentHierarchical logistic regression modelingCoronary artery bypassRecurrent ischemic eventsHours of admissionPrevious cerebrovascular eventsRandomized clinical trialsAcute myocardial infarctionADP receptor inhibitorsLogistic regression modelingPrivate health insurance coverageHealth insurance coverageHospital bleedingHospital switchingAngiographic characteristicsArtery bypassCerebrovascular eventsContemporary US practiceCoronary Treatment
2010
Acute Lead Dislodgements and In-Hospital Mortality in Patients Enrolled in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry
Cheng A, Wang Y, Curtis JP, Varosy PD. Acute Lead Dislodgements and In-Hospital Mortality in Patients Enrolled in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry. Journal Of The American College Of Cardiology 2010, 56: 1651-1656. PMID: 21050975, DOI: 10.1016/j.jacc.2010.06.037.Peer-Reviewed Original ResearchConceptsNational Cardiovascular Data Registry Implantable Cardioverter Defibrillator RegistryImplantable Cardioverter-Defibrillator RegistryLead dislodgementAcute dislodgementHospital deathAdverse eventsNew York Heart Association functional class IV heart failureAtrial fibrillation/flutterCardiac resynchronization therapy-defibrillator deviceClass IV heart failureCommon adverse eventsIn-Hospital MortalityLow ejection fractionChronic lung diseaseMore comorbiditiesCardiac tamponadeMultivariate adjustmentEjection fractionHeart failureNonischemic cardiomyopathyAtrial fibrillationCerebrovascular diseaseCardiac arrestLung diseasePotential confounders
2004
Association Between Functional Status and Use and Effectiveness of Beta‐Blocker Prophylaxis in Elderly Survivors of Acute Myocardial Infarction
Vitagliano G, Curtis JP, Concato J, Feinstein AR, Radford MJ, Krumholz HM. Association Between Functional Status and Use and Effectiveness of Beta‐Blocker Prophylaxis in Elderly Survivors of Acute Myocardial Infarction. Journal Of The American Geriatrics Society 2004, 52: 495-501. PMID: 15066062, DOI: 10.1111/j.1532-5415.2004.52153.x.Peer-Reviewed Original ResearchMeSH KeywordsActivities of Daily LivingAcute DiseaseAdrenergic beta-AntagonistsAge FactorsAgedAged, 80 and overCross-Sectional StudiesDrug PrescriptionsDrug UtilizationFemaleGeriatric AssessmentHumansLogistic ModelsMaleMultivariate AnalysisMyocardial InfarctionPatient DischargePatient SelectionPractice Patterns, Physicians'Proportional Hazards ModelsRetrospective StudiesSurvival AnalysisTreatment OutcomeUnited StatesConceptsAcute myocardial infarctionHospital dischargeFunctional impairmentElderly patientsMyocardial infarctionAcute myocardial infarction survivorsBeta-blocker prescriptionBeta-blocker prophylaxisBeta-blocker treatmentRetrospective cohort studySimilar survival benefitMain outcome measuresMyocardial infarction survivorsAcute care hospitalsEligible patientsCohort studySurvival benefitCare hospitalFunctional statusNational cohortInfarction survivorsOutcome measuresElderly survivorsPatientsCognitive impairment